Education
About Us
Working with TipRanks
Follow Us
uniQure N.V. (QURE)
NASDAQ:QURE
QURE Analyst Ratings
Strong Buy
11 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
QURE Stock 12 Month Forecast
Average Price Target
$75.50
▲(11.54% Upside)
| Highest Price Target$110.00 | Average Price Target$75.50 | Lowest Price Target$56.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$110
Buy
62.51%
Upside
Reiterated
11/03/25
Optimistic Buy Rating for uniQure Amid Promising AMT-130 Data and Regulatory ProspectsValuation and Risks. We assess uniQure using a risk-adjusted discounted cash flow (DCF) and sum-of-the-parts (SOTP)- based methodology based on free cash flow to the firm (FCFF) and net income per asset, respectively. We assign a probability of success to with anticipated approval in 2026E. We model a build in revenues tied to uniQure's AAV gene therapy platform in the 2030s, leading to a moderate present value. We employ a 12% discount rate and a terminal multiple of 6.0x.
Chardan Capital
$76→$53
Buy
-21.70%
Downside
Reiterated
11/03/25
RBC Capital
$65→$45
Buy
-33.52%
Downside
Reiterated
11/03/25
Wells Fargo
$65→$80
Buy
18.19%
Upside
Reiterated
10/02/25
Cantor Fitzgerald
$47→$80
Buy
18.19%
Upside
Reiterated
09/25/25
Goldman Sachs
$13→$56
Hold
-17.27%
Downside
Reiterated
09/25/25
Leerink Partners
$48→$68
Buy
0.46%
Upside
Reiterated
09/24/25
William Blair
―
Buy
―
Reiterated
09/24/25
Stifel Nicolaus
$30→$65
Buy
-3.97%
Downside
Reiterated
09/24/25
Guggenheim
$28→$95
Buy
40.35%
Upside
Reiterated
09/24/25
Mizuho Securities
$30→$60
Buy
-11.36%
Downside
Reiterated
09/24/25
Truist Financial
$8.95
Buy
-86.78%
Downside
Reiterated
12/10/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$110
Buy
62.51%
Upside
Reiterated
11/03/25
Optimistic Buy Rating for uniQure Amid Promising AMT-130 Data and Regulatory ProspectsValuation and Risks. We assess uniQure using a risk-adjusted discounted cash flow (DCF) and sum-of-the-parts (SOTP)- based methodology based on free cash flow to the firm (FCFF) and net income per asset, respectively. We assign a probability of success to with anticipated approval in 2026E. We model a build in revenues tied to uniQure's AAV gene therapy platform in the 2030s, leading to a moderate present value. We employ a 12% discount rate and a terminal multiple of 6.0x.
Chardan Capital
$76→$53
Buy
-21.70%
Downside
Reiterated
11/03/25
RBC Capital
$65→$45
Buy
-33.52%
Downside
Reiterated
11/03/25
Wells Fargo
$65→$80
Buy
18.19%
Upside
Reiterated
10/02/25
Cantor Fitzgerald
$47→$80
Buy
18.19%
Upside
Reiterated
09/25/25
Goldman Sachs
$13→$56
Hold
-17.27%
Downside
Reiterated
09/25/25
Leerink Partners
$48→$68
Buy
0.46%
Upside
Reiterated
09/24/25
William Blair
―
Buy
―
Reiterated
09/24/25
Stifel Nicolaus
$30→$65
Buy
-3.97%
Downside
Reiterated
09/24/25
Guggenheim
$28→$95
Buy
40.35%
Upside
Reiterated
09/24/25
Mizuho Securities
$30→$60
Buy
-11.36%
Downside
Reiterated
09/24/25
Truist Financial
$8.95
Buy
-86.78%
Downside
Reiterated
12/10/24
Best Analysts Covering uniQure
1 Month
xxx
Success Rate
18/36 ratings generated profit
Average Return
+1.55%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +1.55% per trade.
3 Months
xxx
Success Rate
18/36 ratings generated profit
Average Return
+6.86%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +6.86% per trade.
1 Year
Success Rate
17/23 ratings generated profit
Average Return
+185.55%
reiterated a buy rating 29 days ago
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 73.91% of your transactions generating a profit, with an average return of +185.55% per trade.
2 Years
xxx
Success Rate
20/23 ratings generated profit
Average Return
+403.82%
reiterated a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 86.96% of your transactions generating a profit, with an average return of +403.82% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
QURE Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
22
23
16
14
8
Buy
7
8
4
14
14
Hold
5
14
12
15
8
Sell
2
1
0
0
0
Strong Sell
0
0
0
0
0
total
36
46
32
43
30
Each month's total comprises the sum of three months' worth of ratings.
QURE Financial Forecast
QURE Stock Forecast FAQ
What is QURE’s average 12-month price target, according to analysts?
Based on analyst ratings, uniQure N.V.’s 12-month average price target is 75.50.
What is QURE’s upside potential, based on the analysts’ average price target?
uniQure N.V. has 11.54% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is QURE a Buy, Sell or Hold?
uniQure N.V. has a consensus rating of Strong Buy which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.
What is uniQure N.V.’s price target?
The average price target for uniQure N.V. is 75.50. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $110.00 ,the lowest forecast is $56.00. The average price target represents 11.54% Increase from the current price of $67.69.
The highest analyst price target is $110.00 ,the lowest forecast is $56.00. The average price target represents 11.54% Increase from the current price of $67.69.
What do analysts say about uniQure N.V.?
uniQure N.V.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of QURE?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.